942 related articles for article (PubMed ID: 29020367)
1. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.
Escaned J; Collet C; Ryan N; De Maria GL; Walsh S; Sabate M; Davies J; Lesiak M; Moreno R; Cruz-Gonzalez I; Hoole SP; Ej West N; Piek JJ; Zaman A; Fath-Ordoubadi F; Stables RH; Appleby C; van Mieghem N; van Geuns RJ; Uren N; Zueco J; Buszman P; Iñiguez A; Goicolea J; Hildick-Smith D; Ochala A; Dudek D; Hanratty C; Cavalcante R; Kappetein AP; Taggart DP; van Es GA; Morel MA; de Vries T; Onuma Y; Farooq V; Serruys PW; Banning AP
Eur Heart J; 2017 Nov; 38(42):3124-3134. PubMed ID: 29020367
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease.
Escaned J; Banning A; Farooq V; Echavarria-Pinto M; Onuma Y; Ryan N; Cavalcante R; Campos CM; Stanetic BM; Ishibashi Y; Suwannasom P; Kappetein AP; Taggart D; Morel MA; van Es GA; Serruys PW
EuroIntervention; 2016 Jun; 12(2):e224-34. PubMed ID: 27290681
[TBL] [Abstract][Full Text] [Related]
3. Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study.
Banning AP; Serruys P; De Maria GL; Ryan N; Walsh S; Gonzalo N; Jan van Geuns R; Onuma Y; Sabate M; Davies J; Lesiak M; Moreno R; Cruz-Gonzalez I; Hoole SP; Piek JJ; Appleby C; Fath-Ordoubadi F; Zaman A; Van Mieghem NM; Uren N; Zueco J; Buszman P; Iniguez A; Goicolea J; Hildick-Smith D; Ochala A; Dudek D; de Vries T; Taggart D; Farooq V; Spitzer E; Tijssen J; Escaned J
Eur Heart J; 2022 Mar; 43(13):1307-1316. PubMed ID: 34617993
[TBL] [Abstract][Full Text] [Related]
4. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
[TBL] [Abstract][Full Text] [Related]
5. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.
Mohr FW; Morice MC; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Morel MA; Van Dyck N; Houle VM; Dawkins KD; Serruys PW
Lancet; 2013 Feb; 381(9867):629-38. PubMed ID: 23439102
[TBL] [Abstract][Full Text] [Related]
6. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study.
Serruys PW; Kogame N; Katagiri Y; Modolo R; Buszman PE; Íñiguez-Romo A; Goicolea J; Hildick-Smith D; Ochala A; Dudek D; Piek JJ; Wykrzykowska JJ; Escaned J; Banning AP; Farooq V; Onuma Y
EuroIntervention; 2019 Jun; 15(3):e244-e252. PubMed ID: 30636684
[TBL] [Abstract][Full Text] [Related]
8. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
Sabatine MS; Bergmark BA; Murphy SA; O'Gara PT; Smith PK; Serruys PW; Kappetein AP; Park SJ; Park DW; Christiansen EH; Holm NR; Nielsen PH; Stone GW; Sabik JF; Braunwald E
Lancet; 2021 Dec; 398(10318):2247-2257. PubMed ID: 34793745
[TBL] [Abstract][Full Text] [Related]
10. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial.
Kappetein AP; Feldman TE; Mack MJ; Morice MC; Holmes DR; Ståhle E; Dawkins KD; Mohr FW; Serruys PW; Colombo A
Eur Heart J; 2011 Sep; 32(17):2125-34. PubMed ID: 21697170
[TBL] [Abstract][Full Text] [Related]
11. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.
Campos CM; van Klaveren D; Farooq V; Simonton CA; Kappetein AP; Sabik JF; Steyerberg EW; Stone GW; Serruys PW;
Eur Heart J; 2015 May; 36(20):1231-41. PubMed ID: 25583761
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial.
Campos CM; Stanetic BM; Farooq V; Walsh S; Ishibashi Y; Onuma Y; Garcia-Garcia HM; Escaned J; Banning A; Serruys PW;
Catheter Cardiovasc Interv; 2015 Nov; 86(6):E229-38. PubMed ID: 25946686
[TBL] [Abstract][Full Text] [Related]
13. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
[TBL] [Abstract][Full Text] [Related]
14. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.
Morice MC; Serruys PW; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Choi JW; Ruzyllo W; Religa G; Huang J; Roy K; Dawkins KD; Mohr F
Circulation; 2014 Jun; 129(23):2388-94. PubMed ID: 24700706
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.
Holm NR; Mäkikallio T; Lindsay MM; Spence MS; Erglis A; Menown IBA; Trovik T; Kellerth T; Kalinauskas G; Mogensen LJH; Nielsen PH; Niemelä M; Lassen JF; Oldroyd K; Berg G; Stradins P; Walsh SJ; Graham ANJ; Endresen PC; Fröbert O; Trivedi U; Anttila V; Hildick-Smith D; Thuesen L; Christiansen EH;
Lancet; 2020 Jan; 395(10219):191-199. PubMed ID: 31879028
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
[TBL] [Abstract][Full Text] [Related]
17. Contemporary Outcomes Following Coronary Artery Bypass Graft Surgery for Left Main Disease.
Modolo R; Chichareon P; Kogame N; Dressler O; Crowley A; Ben-Yehuda O; Puskas J; Banning A; Taggart DP; Kappetein AP; Sabik JA; Onuma Y; Stone GW; Serruys PW
J Am Coll Cardiol; 2019 Apr; 73(15):1877-1886. PubMed ID: 30999989
[TBL] [Abstract][Full Text] [Related]
18. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW
Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
Mäkikallio T; Holm NR; Lindsay M; Spence MS; Erglis A; Menown IB; Trovik T; Eskola M; Romppanen H; Kellerth T; Ravkilde J; Jensen LO; Kalinauskas G; Linder RB; Pentikainen M; Hervold A; Banning A; Zaman A; Cotton J; Eriksen E; Margus S; Sørensen HT; Nielsen PH; Niemelä M; Kervinen K; Lassen JF; Maeng M; Oldroyd K; Berg G; Walsh SJ; Hanratty CG; Kumsars I; Stradins P; Steigen TK; Fröbert O; Graham AN; Endresen PC; Corbascio M; Kajander O; Trivedi U; Hartikainen J; Anttila V; Hildick-Smith D; Thuesen L; Christiansen EH;
Lancet; 2016 Dec; 388(10061):2743-2752. PubMed ID: 27810312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
